Susquehanna Portfolio Strategies »

Viking Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 63k 39.01

More positions owned by Susquehanna Portfolio Strategies

Intel Corporation (INTC)
Abbvie (ABBV)
Sherwin-Williams Company (SHW)
Medtronic SHS (MDT)
Philip Morris International (PM)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Humana (HUM)
Prologis (PLD)
Williams Companies (WMB)
Devon Energy Corporation (DVN)
Equinix (EQIX)
Metropcs Communications (TMUS)
Monster Beverage Corp (MNST)
Cigna Corp (CI)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Viking Therapeutics

FMR
BlackRock
Vanguard Capital Management
Susquehanna International
Vanguard Portfolio Management
State Street Corporation
Two Sigma Investments
Morgan Stanley
Citadel Advisors
Ameriprise Financial
Geode Capital Management
Diadema Partners
American Century Companies
Jane Street
D. E. Shaw & Co

View all funds holding Viking Therapeutics